|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010.
|
|
2
|
Stein U and Schlag PM: Clinical,
biological, and molecular aspects of metastasis in colorectal
cancer. Recent Results Cancer Res. 176:61–80. 2007.
|
|
3
|
Goebeler V, Ruhe D, Gerke V and Rescher U:
Atypical properties displayed by annexin A9, a novel member of the
annexin family of Ca(2+) and lipid binding proteins. FEBS Lett.
546:359–364. 2003.
|
|
4
|
Hawkins TE, Merrifield CJ and Moss SE:
Calcium signaling and annexins. Cell Biochem Biophys. 33:275–296.
2000.
|
|
5
|
Gerke V and Moss SE: Annexins: from
structure to function. Physiol Rev. 82:331–371. 2002.
|
|
6
|
Smid M, Wang Y, Klijn JG, et al: Genes
associated with breast cancer metastatic to bone. J Clin Oncol.
24:2261–2267. 2006.
|
|
7
|
Watanabe T, Itabashi M, Shimada Y, et al:
Japanese Society for Cancer of the Colon and Rectum: Japanese
Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010
for the treatment of colorectal cancer. Int J Clin Oncol. 17:1–29.
2012.
|
|
8
|
Sobin LH and Fleming ID: TNM
Classification of Malignant Tumors, fifth edition (1997). Union
Internationale Contre le Cancer and the American Joint Committee on
Cancer. Cancer. 80:1803–1804. 1997.
|
|
9
|
Mimori K, Mori M, Shiraishi T, et al:
Clinical significance of tissue inhibitor of metalloproteinase
expression in gastric carcinoma. Br J Cancer. 76:531–536. 1997.
|
|
10
|
Mori M, Staniunas RJ, Barnard GF, et al:
The significance of carbonic anhydrase expression in human
colorectal cancer. Gastroenterology. 105:820–826. 1993.
|
|
11
|
Fava RA and Cohen S: Isolation of a
calcium-dependent 35-kilodalton substrate for the epidermal growth
factor receptor/kinase from A-431 cells. J Biol Chem.
259:2636–2645. 1984.
|
|
12
|
Huang KS, Wallner BP, Mattaliano RJ, et
al: Two human 35 kd inhibitors of phospholipase A2 are related to
substrates of pp60v-src and of the epidermal growth factor
receptor/kinase. Cell. 46:191–199. 1986.
|
|
13
|
Morgan RO, Bell DW, Testa JR and Fernandez
MP: Human annexin 31 genetic mapping and origin. Gene. 227:33–38.
1999.
|
|
14
|
Morgan RO and Fernández MP: Molecular
phylogeny of annexins and identification of a primitive homologue
in Giardia lamblia. Mol Biol Evol. 12:967–979. 1995.
|
|
15
|
Morgan RO and Fernandez MP: Annexin gene
structures and molecular evolutionary genetics. Cell Mol Life Sci.
53:508–515. 1997.
|
|
16
|
Braun EL, Kang S, Nelson MA and Natvig DO:
Identification of the first fungal annexin: analysis of annexin
gene duplications and implications for eukaryotic evolution. J Mol
Evol. 47:531–543. 1998.
|
|
17
|
André T, Quinaux E, Louvet C, et al: Phase
III study comparing a semimonthly with a monthly regimen of
fluorouracil and leucovorin as adjuvant treatment for stage II and
III colon cancer patients: final results of GERCOR C96.1. J Clin
Oncol. 25:3732–3738. 2007.
|
|
18
|
Wolpin BM and Mayer RJ: Systemic treatment
of colorectal cancer. Gastroenterology. 134:1296–1310. 2008.
|
|
19
|
Kornmann M, Formentini A, Ette C, et al:
Prognostic factors influencing the survival of patients with colon
cancer receiving adjuvant 5-FU treatment. Eur J Surg Oncol.
34:1316–1321. 2008.
|
|
20
|
Bathe OF, Dowden S, Sutherland F, et al:
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in
patients with resectable liver metastases from colorectal
adenocarcinoma. BMC Cancer. 4:322004.
|
|
21
|
Sadanandam A, Lyssiotis CA, Homicsko K, et
al: A colorectal cancer classification system that associates
cellular phenotype and responses to therapy. Nat Med. 19:619–625.
2013.
|
|
22
|
Iijima M, Kano Y, Nohno T and Namba M:
Cloning of cDNA with possible transcription factor activity at the
G1-S phase transition in human fibroblast cell lines. Acta Med
Okayama. 50:73–77. 1996.
|
|
23
|
Hansen WJ, Cowan NJ and Welch WJ:
Prefoldin-nascent chain complexes in the folding of cytoskeletal
proteins. J Cell Biol. 145:265–277. 1999.
|
|
24
|
Hodgson G, Hager JH, Volik S, et al:
Genome scanning with array CGH delineates regional alterations in
mouse islet carcinomas. Nat Genet. 29:459–464. 2001.
|
|
25
|
Lacy AM, García-Valdecasas JC, Delgado S,
et al: Laparoscopy-assisted colectomy versus open colectomy for
treatment of non-metastatic colon cancer: a randomised trial.
Lancet. 359:2224–2229. 2002.
|
|
26
|
Weeks JC, Nelson H, Gelber S, et al:
Clinical Outcomes of Surgical Therapy (COST) Study Group:
Short-term quality-of-life outcomes following laparoscopic-assisted
colectomy vs open colectomy for colon cancer: a randomized trial.
JAMA. 287:321–328. 2002.
|
|
27
|
Clinical Outcomes of Surgical Therapy
Study Group. A comparison of laparoscopically assisted and open
colectomy for colon cancer. N Engl J Med. 350:2050–2059. 2004.
|
|
28
|
Jayne DG, Guillou PJ, Thorpe H, et al: UK
MRC CLASICC Trial Group: Randomized trial of laparoscopic-assisted
resection of colorectal carcinoma: 3-year results of the UK MRC
CLASICC Trial Group. J Clin Oncol. 25:3061–3068. 2007.
|
|
29
|
Koshariya M, Jagad RB, Kawamoto J, et al:
An update and our experience with metastatic liver disease.
Hepatogastroenterology. 54:2232–2239. 2007.
|
